Skip to main content
Tuesday, November 17, 2026Nov 17

STDs are on the rise. This morning-after-style pill may help

FILE - A pharmacist holds a bottle of the antibiotic doxycycline hyclate in Sacramento, Calif., July 8, 2016. On Tuesday, April 11, 2023, the Centers for Disease Control and Prevention released data about some of the most common infectious diseases in the U.S. The numbers show how chlamydia, gonorrhea and syphilis infections have been accelerating across the country. Meanwhile, the CDC is considering recommending the antibiotic doxycycline to be used after sex to prevent those infections. (AP Photo/Rich Pedroncelli, File)
FILE - A pharmacist holds a bottle of the antibiotic doxycycline hyclate in Sacramento, Calif., July 8, 2016. On Tuesday, April 11, 2023, the Centers for Disease Control and Prevention released data about some of the most common infectious diseases in the U.S. The numbers show how chlamydia, gonorrhea and syphilis infections have been accelerating across the country. Meanwhile, the CDC is considering recommending the antibiotic doxycycline to be used after sex to prevent those infections. (AP Photo/Rich Pedroncelli, File)


NEW YORK (AP) — U.S. health officials released data Tuesday showing how chlamydia, gonorrhea and syphilis cases have been accelerating, but doctors are hoping an old drug will help fight the sexually transmitted infections.

Experts believe STDs have been rising because of declining condom use, inadequate sex education and reduced testing during the COVID-19 pandemic.

Millions of Americans are infected each year. Rates are highest in men who have sex with men, and among Black and Hispanic Americans and Native Americans.

“Sexually transmitted infections are an enormous, low-priority public health problem. And they’ve been a low-priority problem for decades, in spite of the fact that they are the most commonly reported kind of infectious disease,” said Dr. John M. Douglas Jr., a retired health official who lectures at the Colorado School of Public Health.